Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson (PET/MR-P)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by Washington University School of Medicine
Sponsor:
Collaborator:
Astellas Pharma US, Inc.
Information provided by (Responsible Party):
Pamela Woodard, MD, Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT01779869
First received: January 23, 2013
Last updated: December 8, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)